![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
![]() |
EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript PDF
Version | Download Adobe
Acrobat | Comments |
|
![]()
|
![]() |
Dispatch West Nile Virus in Mexico: Evidence of Widespread Circulation since July 2002José G. Estrada-Franco,* Roberto Navarro-Lopez,† David W.C. Beasley,*
Lark Coffey,* Anne-Sophie Carrara,* Amelia Travassos da Rosa,* Tamara
Clements,‡ Eryu Wang,* George V. Ludwig,‡ Arturo Campomanes Cortes,† Pedro
Paz Ramirez,† Robert B. Tesh,* Alan D.T. Barrett,* and Scott C. Weaver*
During the summer of 2002, the Agricultural Ministry of Mexico (SAGARPA) received reports of encephalitis-like illness in horses from several different areas of Mexico, concurrent with reports of West Nile virus (WNV) encephalitis outbreaks in horses along the Texas border in the states of Coahuila, Tamaulipas, and Chihuahua. Other suspected cases were reported from several southern, tropical states. We report the results of an equine serosurvey conducted from July 2002 to March 2003 by the Office of Exotic Diseases of the Agricultural Ministry (CPA-SAGARPA). We also describe the first isolation of WNV in Mexico, in a Common Raven (Corvus corax) from the state of Tabasco.
The Republic of Mexico is divided by the Tropic of Cancer, with temperate, arid climate zones in the north and at higher elevations and humid, subtropical, and tropical climate zones in the south. Our study encompassed most of these climatic zones, as equine serum samples were collected from 3 border states, 1 state on the Tropic of Cancer, and 10 states south of the Tropic of Cancer (Figure 1). Sampled equine populations were chosen on the basis of a history of clinical encephalitis; medical history was provided by owners and corroborated by CPA-SAGARPA veterinarians. In total, 441 serum samples were analyzed for WNV antibodies. Because most serum samples were collected late in the probable virus transmission season, all were first screened for immunoglobulin (Ig) G antibodies, using IgG enzyme-linked immunosorbent assays (ELISA) with a recombinant, envelope protein domain III antigen expressed and purified from Escherichia coli (D.W.C. Beasley, et al., submitted for pub.). Positive samples were confirmed by hemagglutination inhibition (HI) tests against WNV and St. Louis encephalitis virus (SLEV), by 90% plaque reduction neutralization tests (PRNT) against WNV (1), and by ELISA with WNV, SLEV, and Venezuelan equine encephalitis virus (VEEV) antigens and viruses. (The presence of several endemic arboviruses, including SLEV and VEEV, necessitated additional testing.) WNV infection was confirmed if the WNV antibody titer was >fourfold higher than the SLEV titer. To investigate evidence of recent WNV infection, 198 samples were also tested by using both IgG- and IgM-specific ELISA with WNV-infected cell culture antigens (2). Selected samples were tested by ELISA and PRNT for VEEV antibodies to determine if this virus was circulating in areas reporting equine encephalitis. ResultsA total of 441 equine serum samples from 14 states of Mexico were tested (Figure 1). WNV-specific antibodies were detected in 97 (22%) of the samples. These data probably overestimate the true equine seropositivity rate because sampling focused on herds with a history of clinical encephalitis. Representative data from 22 of the WNV-positive samples obtained in five different states are presented in Table 1. No evidence was obtained of SLEV infection in equines, but VEEV-specific antibodies were detected in serum samples from the states of Veracruz and Yucatán. (Horses are vaccinated against VEEV in the states of Chiapas and Oaxaca, so samples from these locations were not tested for VEEV antibodies.) The positive samples, several of which also contained WNV IgG, represent natural VEEV circulation and infection of horses, presumably with enzootic subtype IE strains (3,4). On May 5, 2003, the CPA-SAGARPA received a report of a dead Common Raven
from the El Yumka wildlife preserve in the city of Villahermosa, state
of Tabasco. Although this species is native to Tabasco and other regions
of Mexico, this bird was one of two ravens imported from the United States
in 1999. A necropsy was performed, and virus isolation was attempted on
tissue samples at the CPA-SAGARPA biosafety level 3 facility in Palo Alto,
Mexico City. On May 16, 2003, cytopathic effects were detected in Vero
cells injected with brain suspension. Viral RNA from the isolate was genetically
characterized at the National Institute for Epidemiology and Diagnostics
(InDre) in Mexico City and at the University of Texas Medical Branch in
Galveston. A 2,004-nt genome portion, including the prM-E protein region,
was amplified by using a reverse transcription–polymerase chain reaction
as described previously (5); the resulting amplicons
were sequenced directly with the Big Dye sequencing kit and model 3100
sequencer (Applied Biosystems, Foster City, CA). The sequence of this
WNV isolate (TM171-03, submitted to GenBank under accession no. AY371271)
was aligned with all homologous WNV sequences of the same length available
from the GenBank library (homologous to nt 466–2,469 in the Flamingo382
strain, GenBank accession no. AF196835), and phylogenetic trees were constructed
by using maximum parsimony, maximum likelihood (incorporating empirical
base frequencies, a general time-reversible substitution model with the
following frequencies: A Comparison of nucleotide sequences indicated mutations at 9 nt (0.45%)
of the Mexican TM171-03 sequence compared to the prototype NY99 strain
(Flamingo382, GenBank accession no. AF196835). Some of these nucleotide
positions vary among other strains sampled worldwide, suggesting that
they are not under strong purifying selection. Comparison with sequences
of Year 2002 Texas strains showed only one shared mutation (genomic position
2466 C ConclusionsTwo recent publications reported serologic evidence of WNV infection among equines in the states of Yucatán and Coahuila from serum samples collected beginning in July and December 2002, respectively (10,11). We obtained serologic evidence of more widespread circulation of WNV in five other Mexican states, also dating back to July 2002. We also report the first isolation of WNV from Mexico from a dead Common Raven that resided in a wildlife preserve in Tabasco. Genetic studies indicated that the Mexican WNV strain was likely introduced from the central United States. The level of genetic divergence (9 nt) of the Mexican isolate and the unique amino acid substitutions in the prM and E proteins when compared to all other North American WNV isolates suggest that the Mexican strain has been evolving independently for some time and did not simply enter Mexico recently from Texas. We speculate that this strain descended from a WNV strain introduced into the Yucatán peninsula by migrating birds. Nucleotide sequences of viruses isolated from Mexican states close to the U.S. border, once obtained, may more closely resemble strains isolated in Texas during 2002. Of particular interest is the overlap in distribution of WNV and VEEV (serologic data for VEEV not shown) in the southern Mexican states of Veracruz and Yucatán; the presence of other flaviviruses like SLEV in these states is also likely. Both WNV and VEEV produce clinically similar neurologic disease in horses, and past, presumptive diagnoses of VEEV may have been inaccurate. Steps are now in place at the Mexico City headquarters of the Animal Health Division of SAGARPA to implement appropriate laboratory diagnosis for flaviviruses and alphaviruses. Additionally, field personnel are instructed to investigate epidemiologic signs of possible WNV infection including avian death and unusual human neurologic syndromes. The biologic and epidemiologic consequences of mosquito-borne encephalitis viruses (12) cocirculating in the same ecosystem should be examined. The impact of WNV on human health in regions (such as Mexico) where inhabitants may have extensive prior exposure to other flaviviruses such as dengue, SLEV, Ilheus, Bussuquara, Jutiapa, and Yellow fever viruses may differ from that in regions (e.g., the United States and Canada) where human exposure to flaviviruses is very limited. WNV infection in persons with previous flavivirus immunity, which could either attenuate disease because of cross-protective antibodies (13) or potentially worsen disease because of immune enhancement (14), should be studied. Our ongoing VEEV surveillance in southern Mexico may identify differences in transmission habitats for VEEV and WNV and assist with optimizing virus containment efforts. Acknowledgments
References
|
|
||||||||||||
|
||||||||||||
![]() |
![]() |
|
![]() |
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
![]() |
![]() |
This page posted October
16, 2003 |
![]() |
![]() |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |
![]() |